Variation in LPA is associated with Lp(a) levels in three populations from the third National Health and Nutrition Examination Survey

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Dumitrescu, Logan ^a,b   Glenn, Kimberly ^a   Brown Gentry, Kristin ^a   Shephard, Cynthia ^c   Wong, Michelle ^c   Rieder, Mark J ^c   Smith, Joshua D ^c   Nickerson, Deborah A ^c   Crawford, Dana C ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN A;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HISPANIC; HUMAN; HUMAN EXPERIMENT; MALE; POPULATION GENETICS; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; CAUCASIAN; ETHNIC AND RACIAL GROUPS; GENETICS; NEGRO;

AFRICAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC VARIATION; GENOTYPE; HISPANIC AMERICANS; HUMANS; LIPOPROTEIN(A); POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION GROUPS;

EID: 79551558751     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016604     Document Type: Article

References (56)

1. Bennet A, Di Angelantonio E, Erqou S, Eiriksdottir G, Sigurdsson G, et al. (2008) Lipoprotein(a) Levels and Risk of Future Coronary Heart Disease: Large-Scale Prospective Data. Arch Intern Med 168: 598-608.
2. Berglund L, Ramakrishnan R (2004) Lipoprotein(a): An Elusive Cardiovascular Risk Factor. Arterioscler Thromb Vasc Biol 24: 2219-2226.
3. Danesh J, Collins R, Peto R (2000) Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 102: 1082-1085.
4. The Emerging Risk Factors Collaboration (2009) Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality. JAMA: The Journal of the American Medical Association 302: 412-423.
5. Guyton JR, Dahlen GH, Patsch W, Kautz JA, Gotto AM, Jr. (1985) Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B. Arterioscler Thromb Vasc Biol 5: 265-272.
6. Heiss G, Schonfeld G, Johnson JL, Heyden S, Hames CG, et al. (1984) Blackwhite differences in plasma levels of apolipoproteins: the Evans County Heart Study. Am Heart J 108: 807-814.
7. Moliterno DJ, Jokinen EV, Miserez AR, Lange RA, Willard JE, et al. (1995) No association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis in African-Americans. Arterioscler Thromb Vasc Biol 15: 850-855.
8. Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, et al. (2001) Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 104: 1108-1113.
9. Sorrentino MJ, Vielhauer C, Eisenbart JD, Fless GM, Scanu AM, et al. (1992) Plasma lipoprotein (a) protein concentration and coronary artery disease in black patients compared with white patients. Am J Med 93: 658-662.
10. Srinivasan SR, Dahlen GH, Jarpa RA, Webber LS, Berenson GS (1991) Racial (black-white) differences in serum lipoprotein (a) distribution and its relation to parental myocardial infarction in children. Bogalusa Heart Study. Circulation 84: 160-167.
11. Kamboh MI, Rewers M, Aston CE, Hamman RF (1997) Plasma apolipoprotein A-I, apolipoprotein B, and lipoprotein(a) concentrations in normoglycemic Hispanics and non-Hispanic whites from the San Luis Valley, Colorado. Am J Epidemiol 146: 1011-1018.
12. Haffner SM, Gruber KK, Morales PA, Hazuda HP, Valdez RA, et al. (1992) Lipoprotein(a) concentrations in Mexican Americans and non-Hispanic whites: the San Antonio Heart Study. Am J Epidemiol 136: 1060-1068.
13. Chretien JP, Coresh J, Berthier-Schaad Y, Kao WH, Fink NE, et al. (2006) Three single-nucleotide polymorphisms in LPA account for most of the increase in lipoprotein(a) level elevation in African Americans compared with European Americans. J Med Genet 43: 917-923.
14. Marcovina SM, Koschinsky ML, Albers JJ, Skarlatos S (2003) Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: recent advances and future directions. Clin Chem 49: 1785-1796.
15. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, et al. (1992) Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 90: 52-60.
16. Boomsma DI, Knijff P, Kaptein A, Labeur C, Martin NG, et al. (2000) The effect of apolipoprotein(a)-, apolipoprotein E-, and apolipoprotein A4-polymorphisms on quantitative lipoprotein(a) concentrations. Twin Res 3: 152-158.
17. Ali S, Bunker CH, Aston CE, Ukoli FA, Kamboh MI (1998) Apolipoprotein A kringle 4 polymorphism and serum lipoprotein (a) concentrations in African blacks. Hum Biol 70: 477-490.
18. Kraft HG, Lingenhel A, Pang RW, Delport R, Trommsdorff M, et al. (1996) Frequency distributions of apolipoprotein(a) kringle IV repeat alleles and their effects on lipoprotein(a) levels in Caucasian, Asian, and African populations: the distribution of null alleles is non-random. Eur J Hum Genet 4: 74-87.
19. Schmidt K, Kraft HG, Parson W, Utermann G (2006) Genetics of the Lp(a)/ apo(a) system in an autochthonous Black African population from the Gabon. Eur J Hum Genet 14: 190-201.
20. Chiu L, Hamman RF, Kamboh MI (2000) Apolipoprotein A polymorphisms and plasma lipoprotein(a) concentrations in non-Hispanic Whites and Hispanics. Hum Biol 72: 821-835.
21. Rainwater DL, Kammerer CM, Vandeberg JL, Hixson JE (1997) Characterization of the genetic elements controlling lipoprotein(a) concentrations in Mexican Americans. Evidence for at least three controlling elements linked to LPA, the locus encoding apolipoprotein(a). Atherosclerosis 128: 223-233.
22. Clarke R, Peden JF, Hopewell JC, Kyriakou T, Goel A, et al. (2009) Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 361: 2518-2528.
23. Lanktree MB, Anand SS, Yusuf S, Hegele RA (2010) Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians. Circ Cardiovasc Genet 3: 39-46.
24. Ober C, Nord AS, Thompson EE, Pan L, Tan Z et al (2009) Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6q. J Lipid Res 50: 798-806.
25. Crawford DC, Peng Z, Cheng JF, Boffelli D, Ahearn M, et al. (2008) LPA and PLG sequence varaition and kringle IV-2 copy number in two populations. Hum Hered 66: 199-209.
26. Center for Disease Control and Prevention (1996) The Third National Health and Nutrition Examination Survey, 1988-94. Reference manuals and reports (CD ROM). US Department of Health and Human Services National Center for Health Statistics.
27. Marcovina SM, Albers JJ, Wijsman E, Zhang ZH, Chapman NH, et al. (1996) Differences in Lp(a) concentrations and apo(a) polymorphs between black and white Americans. J Lipid Res 37: 2569-2585.
28. Crawford DC, Peng Z, Cheng JF, Boffelli D, Ahearn M, et al. (2008) LPA and PLG sequence variation and kringle IV-2 copy number in two populations. Hum Hered 66: 199-209.
29. Bamshad M (2005) Genetic influences on health: does race matter? JAMA 294: 937-946.
30. Carlson CS, Eberle MA, Rieder MJ, Smith JD, Kruglyak L, et al. (2003) Additional SNPs and linkage-disequilibrium analyses are necessary for wholegenome association studies in humans. Nat Genet 33: 518-521.
31. (2003) The International HapMap Project. Nature 426: 789-796.
32. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, et al. (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449: 851-861.
33. Crawford DC, Carlson CS, Rieder MJ, Carrington DP, Yi Q, et al. (2004) Haplotype diversity across 100 candidate genes for inflammation, lipid metabolism, and blood pressure regulation in two populations. Am J Hum Genet 74: 610-622.
34. Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding nonsynonymous variants on protein function using the SIFT algorithm. Nat Protocols 4: 1073-1081. 10.1038/nprot.2009.86.
35. Boffa MB, Marcovina SM, Koschinsky ML (2004) Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models. Clin Biochem 37: 333-343.
36. Ali S, Bunker CH, Aston CE, Ukoli FA, Kamboh MI (1998) Apolipoprotein A kringle 4 polymorphism and serum lipoprotein (a) concentrations in African blacks. Hum Biol 70: 477-490.
37. Kraft HG, Lingenhel A, Pang RW, Delport R, Trommsdorff M, et al. (1996) Frequency distributions of apolipoprotein(a) kringle IV repeat alleles and their effects on lipoprotein(a) levels in Caucasian, Asian, and African populations: the distribution of null alleles is non-random. Eur J Hum Genet 4: 74-87.
38. Schmidt K, Kraft HG, Parson W, Utermann G (2006) Genetics of the Lp(a)/ apo(a) system in an autochthonous Black African population from the Gabon. Eur J Hum Genet 14: 190-201.
39. Choudhry S, Seibold MA, Borrell LN, Tang H, Serebrisky D, et al. (2007) Dissecting complex diseases in complex populations: asthma in latino americans. Proc Am Thorac Soc 4: 226-233.
40. Lanktree MB, Rajakumar C, Brunt JH, Koschinsky ML, Connelly PW, et al. (2009) Determination of lipoprotein(a) kringle repeat number from genomic DNA: copy number variation genotyping using qPCR. J Lipid Res 50: 768-772.
41. Kraft HG, Haibach C, Lingenhel A, Brunner C, Trommsdorff M, et al. (1995) Sequence polymorphism in kringle IV 37 in linkage disequilibrium with the apolipoprotein (a) size polymorphism. Hum Genet 95: 275-282.
42. Luke MM, Kane JP, Liu DM, Rowland CM, Shiffman D, et al. (2007) A polymorphism in the protease-like domain of apolipoprotein(a) is associated with severe coronary artery disease. Arterioscler Thromb Vasc Biol 27: 2030-2036.
43. Ogorelkova M, Kraft HG, Ehnholm C, Utermann G (2001) Single nucleotide polymorphisms in exons of the apo(a) kringles IV types 6 to 10 domain affect Lp(a) plasma concentrations and have different patterns in Africans and Caucasians. Hum Mol Genet 10: 815-824.
44. Barkley RA, Brown AC, Hanis CL, Kardia SL, Turner ST, et al. (2003) Lack of genetic linkage evidence for a trans-acting factor having a large effect on plasma lipoprotein[a] levels in African Americans. J Lipid Res 44: 1301-1305.
45. Mooser V, Scheer D, Marcovina SM, Wang J, Guerra R, et al. (1997) The Apo(a) gene is the major determinant of variation in plasma Lp(a) levels in African Americans. Am J Hum Genet 61: 402-417.
46. Scholz M, Kraft HG, Lingenhel A, Delport R, Vorster EH, et al. (1999) Genetic control of lipoprotein(a) concentrations is different in Africans and Caucasians. Eur J Hum Genet 7: 169-178.
47. Crawford DC, Sanders CL, Qin X, Smith JD, Shephard C, et al. (2006) Genetic Variation Is Associated With C-Reactive Protein Levels in the Third National Health and Nutrition Examination Survey. Circulation 114: 2458-2465.
48. Chang Mh, Lindegren ML, Butler MA, Chanock SJ, Dowling NF, et al. (2009) Prevalence in the United States of Selected Candidate Gene Variants: Third National Health and Nutrition Examination Survey, 1991-1994. Am J Epidemiol 169: 54-66.
49. Steinberg KK, Sanderlin KC, Ou C-Y, Hannon WH, McQuillan GM, et al. (1997) DNA banking in epidemiologic studies. Epidemiol Rev 19: 156-162.
50. Centers for Disease Control and Prevention (2004) Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-94. Bethesda, MD.
51. Centers for Disease Control and Prevention (1996) Third National Health and Nutrition Examination Survey, 1988-94, Plan and Operations Procedures Manuals.
52. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74: 106.
53. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, et al. (2007) PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses. Am J Hum Genet 81: 559-575.
54. Pendergrass S, Dudek SM, Roden DM, Crawford DC, Ritchie MD (2011) Visual integration of results from a large DNA biobank (biovu) using synthesisview. Pac Symp Biocomput 265-275.
55. Pendergrass S, Dudek S, Crawford D, Ritchie M (2010) Synthesis-View: visualization and interpretation of SNP association results for multi-cohort, multi-phenotype data and meta-analysis. BioData Mining. In press.
56. Lohr SL (1999) Sampling: Design and Analysis. Pacific Grove, Calif: Duxbury Press.